Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma
CNS Neuroscience & Therapeutics · 2024-05 · 30 (5)
DOI: 10.1111/cns.14720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 07.05.2024. Verfasst von Jinxin Lan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Electric Stimulation Therapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Glioblastoma multiforme (GBM) is an aggressive malignant tumor with a high mortality rate and is the most prevalent primary intracranial tumor that remains incurable. The current standard treatment, which involves surgery along with concurrent radiotherapy and chemotherapy, only yields a survival time of 14–16 months. However, the introduction of tumor electric fields therapy (TEFT) has provided a glimmer of hope for patients with newly diagnosed and recurrent GBM, as it has been shown to extend the median survival time to 20 months. The combination of TEFT and other advanced therapies is a promising trend in the field of GBM, facilitated by advancements in medical technology.
Aims
In this review, we provide a concise overview of the mechanism and efficacy of TEFT. In addition, we mainly discussed the innovation of TEFT and our proposed blueprint for TEFT implementation.
Conclusion
Tumor electric fields therapy is an effective and highly promising treatment modality for GBM. The full therapeutic potential of TEFT can be exploited by combined with other innovative technologies and treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Chinese PLA General Hospital, Beijing, China.
- School of Medicine, Nankai University, Tianjin, China.
- Medical School of Chinese PLA, Beijing, China.
- Department of Neurosurgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
- Department of Neurosurgery, Hainan Hospital of Chinese PLA General Hospital, Hainan, China.
ORCID-Profile: Jinxin Lan, Hongyu Liu, Jialin Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lan, J., Liu, Y., Chen, J., Liu, H., Feng, Y., Liu, J., & Chen, L. (2024). Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma. CNS Neuroscience & Therapeutics, 30(5). https://doi.org/10.1111/cns.14720
Vancouver
Lan J, Liu Y, Chen J, Liu H, Feng Y, Liu J, et al. Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma. CNS Neuroscience & Therapeutics. 2024;30(5). doi:10.1111/cns.14720
BibTeX
@article{Lan2024,
author = {Lan, Jinxin and Liu, Yuyang and Chen, Junyi and Liu, Hongyu and Feng, Yaping and Liu, Jialin and Chen, Ling},
title = {Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {5},
doi = {10.1111/cns.14720}
}
EUVIMED